Cargando…
Heart failure prevention and monitoring strategies in HER2-positive breast cancer: a narrative review
PURPOSE: Cardiotoxicity from anti-human epidermal growth factor receptor 2 (HER2) therapy carries a short- and long-term risk of incident heart failure and increased cardiovascular mortality in patients with breast cancer. Interruptions in anti-HER2 therapy due to cardiotoxicity can lead to suboptim...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7820093/ https://www.ncbi.nlm.nih.gov/pubmed/33481134 http://dx.doi.org/10.1007/s10549-021-06096-9 |